National Healthcare Properties, Inc.
NHPReal Estate Reit Healthcare Facilities
National Healthcare Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $342.3 million, down 3.25% from fiscal 2024.
- Revenue
- +19.8%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +79.0%
Quarter to September 2026, against a year earlier
After hours trading: 14.82, unchanged, last trade Fri 4:01pm Eastern.
Follow NHP
Alert me
Where the cash went Q3 FY2026, quarter to Sep 30, 2026
Free cash flow was −$62.1M: capital expenditures were more than operating cash flow. Cash fell by $158.3M. Lines the picture does not name came to −$4.5M. What is a cash flow statement?
- Free cash flow
- −$62.1M −394.4% of operating cash flow
- Returned to shareholders
- $93.9M
- Debt, net
- $5.0M borrowed
- Change in cash
- −$158.3M over the period
| Operating cash flow | 15.7 |
|---|---|
| Capital expenditures | −77.8 |
| Free cash flow | −62.1 |
| Into investments, net | −2.9 |
| Dividends | −9.4 |
| Buybacks, net | −84.5 |
| Debt raised, net | +5.0 |
| Other | −4.5 |
| Change in cash | −158.3 |
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Operating cash flow | $10M | $9M | $22M | $16M |
| Capex | −$2M | −$5.3M | −$103M | −$78M |
| Free cash flow | $8M | $3.7M | −$82M | −$62M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more quarters Free account |
(22.80) | (4.28) | (5.39) | 20.24 |
Depreciation & Amortization |
19.17 | 17.16 | 17.23 | 23.66 | |
Non Cash Items (Other) |
14.70 | 1.00 | 5.36 | (27.80) | |
Accounts Receivable Change |
(4.68) | (0.21) | 1.86 | 1.33 | |
Change in payables and accrued liability |
(5.38) | (2.19) | 3.10 | 2.59 | |
Change in other assets and liabilities |
8.97 | (2.46) | (0.56) | (4.28) | |
Operating Cash Flow |
9.96 | 9.01 | 21.61 | 15.74 | |
Capital expenditures |
(1.95) | (5.26) | (103.37) | (77.80) | |
Short Term Investments Change (Net) |
(1.38) | (0.15) | 0.00 | (2.86) | |
Investing cash flow |
(3.33) | (5.42) | (103.37) | (80.65) | |
Repayment/Issuance of Debt (Net) |
12.35 | (1.66) | (187.66) | 5.03 | |
Equity Repurchase (Common, Net) |
(0.98) | — | 499.42 | (2.25) | |
Equity Repurchase (Preffered, Net) |
(0.92) | — | (25.61) | (82.25) | |
Dividends Paid (Total) |
(3.33) | (3.34) | (3.34) | (9.43) | |
Other financial activities |
(7.83) | (0.44) | (5.26) | (4.53) | |
Financing cash flow |
(0.71) | (5.45) | 277.55 | (93.42) | |
Change in Cash |
5.92 | (1.85) | 195.78 | (158.34) | |
Beginning Cash |
0.00 | 108.45 | 0.00 | 0.00 | |
Ending Cash |
5.92 | 106.60 | 195.78 | (158.34) | |
Stock Based Compensation |
1.86 | 0.61 | 1.62 | 2.13 | |
Dividends Paid (Common) |
(0.04) | (0.05) | (0.05) | (5.58) | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(1.10) | (4.86) | 4.41 | (0.36) | |
Investments Change (Net) |
(1.38) | (0.15) | 0.00 | (2.86) | |
Dividends Paid (Preffered) |
(3.28) | (3.29) | (3.29) | (3.85) | |
Issuance/Purchase of Shares |
(1.90) | — | 473.81 | (84.50) |